您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > MC-VA-PABC-MMAE
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
MC-VA-PABC-MMAE
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
MC-VA-PABC-MMAE图片
CAS NO:1818864-51-5
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议

产品介绍
MC-VA-PABC-MMAE 是抗体偶联药物 ADC 的一部分。MC-VA-PABC-MMAE 由 ADC linker (peptide MC-VA-PABC) 和强效微管蛋白聚合抑制剂 MMAE 偶联而成。
Cas No.1818864-51-5
分子式C65H99N9O14
分子量1230.53
溶解度DMSO : 100 mg/mL (81.27 mM; Need ultrasonic)
储存条件Store at -20°C, sealed storage, away from moisture and light
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

MC-VA-PABC-MMAE is a drug-linker conjugate for ADC. MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE [1][2].

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].

[1]. Wang Y, et al. Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766. [2]. Cazzamalli S, et al. Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma. J Control Release. 2017 Jan 28;246:39-45.